Neurobrave Overview
NeuroBrave uses cloud-based infrastructure, advanced signal processing, and DNN proprietary algorithms to create a standardized software solution (NeuroSpeed OS) for analyzing neural biomarkers/insights using any hardware, including smartphones, smartwatches, and many other wearables. NeuroBrave's operating system aims to save money and drastically shorten any neuroscience venture's time to market by automatically extracting and analyzing the desired biomarker.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Smartwatch Tracks Your Mental Health Through Your Heartbeat
NeuroBrave, an Israeli startup, has developed NeuroSpeed AI analysis software that uses smartwatch sensors to track users emotional wellbeing by analyzing heart rate variability (HRV). The company operates on a B2B model, partnering with insurance companies, healthcare providers, and wellness apps. NeuroBrave is expanding its technology to other wearable devices and has partnered with Qualcomm and Garmin. The company is also raising funds in multiple countries and has launched an initiative in Israel to support communities affected by the October 7 Hamas attack. NeuroBraves technology is being used in collaboration with Ichilov Hospital to advance brain-computer interface research. The company plans to expand significantly due to the global shortage of mental health experts.
CustomersPartnersInvestmentExpand
growth-positive
בצבא הם ניסו לפצח חידה. עשור אחר כך הם עלו על הפתרון
NeuroBrave, a company founded by Oleg Ariotkin and Dror Talisman, has developed technology that is already integrated into Garmin wristbands and is on its way to being used in Sony headphones. The companys algorithms have the potential to enable communication without speaking. The article describes a hospital scenario where a young woman with implanted electrodes is part of a research study. This development signifies a positive growth impact for NeuroBrave as it expands its customer base and partnerships with major companies like Garmin and Sony.
CustomersPartners
growth-positive
NeuroBrave, Sourasky Medical Center partner for generative AI project
NeuroBrave, an AI company based in Israel, has partnered with Sourasky Medical Center’s Functional Neurology Unit in Tel Aviv to accelerate research into complex neurological conditions. The partnership aims to use AI for real-time translation of thoughts and intentions, enabling paralyzed patients to communicate and operate devices. NeuroBraves AI-enabled NeuroSpeed OS platform decodes biomarkers and neuromarkers of emotional, cognitive, and behavioral states in real time. The company previously partnered with Garmin Health solutions and received seed funding from Venture Israel, Labs/02, and Samurai Incubate.
PartnersInvestment
growth-positive
NeuroBrave Combines AI, Signal Processing And Neuroscience To Make Your Wearable Smarter
Israeli startup NeuroBrave is using advanced signal processing algorithms, deep learning models and generative AI to turn data from personal information collectors into actionable insights. The company provides software to component manufacturers and developers of consumer devices that can help reduce stress levels, maintain high productivity, improve sleep patterns and more. NeuroBrave was founded four years ago by veterans of Israeli military intelligence with extensive expertise in robotics and signal processing. The company has so far partnered with 25 companies from semiconductors manufacturers to healthcare providers, in the U.S., U.K., the European Union, Israel, and Japan.
PartnersExpand
growth-positive
NeuroBrave Secure an investment from the leading Italian investors IAG to boost its business development | Italian Angels for Growth
NeuroBrave, an Israeli deep tech startup, has secured a significant investment from Italian Angels for Growth (IAG). The investment will allow NeuroBrave to expand its research and development and business development teams in the EU, Japan, and the US. The company aims to strengthen agreements with current customers and partners, who are leading manufacturers of wearable devices, consumer electronics, and chips. NeuroBraves flagship product, NeuroSpeed OS™, is an AI platform that translates bio-electrical signals from wearable sensors to provide real-time insights on the users emotional and cognitive states. The company operates in the rapidly growing market of wearable devices, which is expected to reach $265 billion by 2026. NeuroBraves unique competitive advantage lies in its co-founders, management team, and intellectual property in signals analysis and cognitive state analysis.
InvestmentPartnersCustomers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $3M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 4 |
| Investors | 6 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | neurobrave.com/ |
Locations
Hebron Road 24, Jerusalem, Israel
Photos & Videos
1 item(s)
